Cargando…
Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
BACKGROUND: Muscle invasive bladder cancer (MIBC) remains amongst the deadliest genitourinary malignancies due to treatment failure and extensive molecular heterogeneity, delaying effective targeted therapeutics. Hypoxia and nutrient deprivation, oversialylation and O-glycans shortening are salient...
Autores principales: | Peixoto, Andreia, Ferreira, Dylan, Azevedo, Rita, Freitas, Rui, Fernandes, Elisabete, Relvas-Santos, Marta, Gaiteiro, Cristiana, Soares, Janine, Cotton, Sofia, Teixeira, Beatriz, Paulo, Paula, Lima, Luís, Palmeira, Carlos, Martins, Gabriela, Oliveira, Maria José, Silva, André M. N., Santos, Lúcio Lara, Ferreira, José Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188679/ https://www.ncbi.nlm.nih.gov/pubmed/34108014 http://dx.doi.org/10.1186/s13046-021-01988-6 |
Ejemplares similares
-
Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology
por: Fernandes, Elisabete, et al.
Publicado: (2020) -
Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells
por: Fernandes, Elisabete, et al.
Publicado: (2020) -
Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours
por: Cotton, Sofia, et al.
Publicado: (2017) -
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
por: Gaiteiro, Cristiana, et al.
Publicado: (2022) -
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
por: Azevedo, Rita, et al.
Publicado: (2018)